National Bank of Canada’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,550
Closed -$4K 2982
2022
Q3
$4K Sell
1,550
-150
-9% -$364 ﹤0.01% 2418
2022
Q2
$2K Buy
1,700
+1,000
+143% +$1.68K ﹤0.01% 2660
2022
Q1
$2K Hold
700
﹤0.01% 2746
2021
Q4
$5K Buy
+700
New +$6.8K ﹤0.01% 2556

National Bank of Canada's ZY Position: Q4 2022 in Review

National Bank of Canada sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 1,550 shares — an estimated $4K sold.

National Bank of Canada first reported a position in ZY in Q4 2021 and held it in 4 quarters. The position peaked at $5K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • National Bank of Canada reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • National Bank of Canada sold 1,550 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $4K.
  • National Bank of Canada first reported a position in Zymergen Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • National Bank of Canada's Zymergen Inc. Common Stock position peaked at $5K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on National Bank of Canada's 13F filing for Q4 2022, filed 24 Jan 2023.